StatPearls, LLC

  • Depression, Postpartum

Brexanolone

Brexanolone is a medication used in the treatment of postpartum depression in adult women. Brexanolone is classified as a GABA-A modulator. This course discussion focuses on the indications, contraindications, FDA-issued box warnings, and monitoring for brexanolone as a valuable agent in treating postpartum depression. Additionally, this activity reviews pharmacokinetics, toxicity, and the mechanism of action of brexanolone. Understanding the complex pharmacology of brexanolone enables healthcare professionals to tailor treatments to meet the individual needs of patients effectively. This continuing education activity is designed to provide essential knowledge and practical tools for the optimal administration of brexanolone. This educational initiative highlights the significant role of the interprofessional healthcare team in managing brexanolone therapy. Healthcare professionals can make well-informed, evidence-based decisions through this CME activity, which aims to improve patient care and achieve the best outcomes. It focuses on strategies to minimize adverse reactions while maximizing the effectiveness of brexanolone. This activity will empower healthcare professionals with the proficiency to deliver safe, effective, and individualized care during brexanolone administration.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABPATH — Lifelong LearningUp to 1 pointABTS — Accredited CMEUp to 1 pointABIM — Medical KnowledgeUp to 1 pointABS — Self-AssessmentUp to 1 pointABP — Lifelong Learning and Self-AssessmentUp to 1 pointABTS — Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left